Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNN4 | O15554 | 1/20 | 0.41 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | SRC | P12931 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 3/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.32 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.32 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8096308 | 0.83 | DGAT1 (0.46) | KCNN4DGAT1ALDH1A1SRCTSHR | |
| SCHEMBL18868424 | 0.75 | ALDH1A1 (0.44) | KCNN4DGAT1ALDH1A1SRCTSHR | |
| SCHEMBL28117259 | 0.73 | ALDH1A1 (0.40) | KCNN4DGAT1ALDH1A1SRCTSHR | |
| SCHEMBL1010735 | 0.73 | DGAT1 (0.56) | KCNN4DGAT1ALDH1A1SRCTSHR | |
| SCHEMBL2097450 | 0.73 | DGAT1 (0.44) | KCNN4DGAT1ALDH1A1SRCTSHR | |
| Pivalate SCHEMBL29716693 | 0.73 | DGAT1 (0.44) | KCNN4DGAT1ALDH1A1SRCTSHR | |
| SCHEMBL20090047 | 0.71 | TSHR (0.31) | TSHR | |
| Hydrochloric Acid SCHEMBL10829675 | 0.71 | DGAT1 (0.54) | KCNN4DGAT1ALDH1A1SRCTSHR | |
| SCHEMBL21393608 | 0.71 | KCNN4 (0.38) | KCNN4DGAT1ALDH1A1SRCTSHR | |
| SCHEMBL4070809 | 0.71 | ALDH1A1 (0.45) | KCNN4DGAT1ALDH1A1SRCTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180107114-A1 | PHOTOSENSITIVE RESIN COMPOSITION, POLYAMIDE RESIN, METHOD FOR PRODUCING POLYAMIDE RESIN, COMPOUND, METHOD FOR PRODUCING COMPOUND, METHOD FOR PRODUCING CURED FILM, AND CURED FILM | TOKYO OHKA KOGYO CO LTD (JP) | 2018-04-19 | — | — | US | disclosed |
| US-20090142809-A1 | Method for Cleaving Cervimycin Monoesters | LEIBNIZ-INSTITUT FÜR NATURSTOFF-FORSCHUNG UND INFE (DE) | 2009-06-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180107114-A1 | PHOTOSENSITIVE RESIN COMPOSITION, POLYAMIDE RESIN, METHOD FOR PRODUCING POLYAMIDE RESIN, COMPOUND, METHOD FOR PRODUCING COMPOUND, METHOD FOR PRODUCING CURED FILM, AND CURED FILM | RARA, LCP1, CUTA | KCNN4 4144/4885DGAT1 552/4885ALDH1A1 1996/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.